Research ID
hum0445-v2Release info
Research title
Cancer genomics for elucidation of molecular mechanisms of carcinogenecis and progression in lung cancer
Research overview
- Aims
- The objective of this project is to analyze genomic aberrations and gene expression changes such as mutations, deletions, amplifications, and hypermethylation in human lung cancer cells at the somatic cell level, and to contrast these with clinicopathological information to elucidate the molecular mechanisms and characteristics of lung cancer development and progression at the genetic level.
- Methods
- RNA-seq, Whole exome sequencing
- Participants/materials
- Lung adenocarcinoma, Non-small cell lung cancer
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000897 | NGS (RNA-seq) |
| Controlled-access (Type I) | 2025-05-21 |
Data provider
- Principal investigator
- Takashi Kohno
- Affiliation
- Division of Genome Biology, National Cancer Center Research Institute
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
The Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) | Research aimed at a comprehensive exploration of drug targets based on genomic data in multi-layered disease omics analysis |
|
The Health, and Labor Sciences Research Expenses for Commission | Research on the establishment of a new treatment for advanced non-small cell lung cancer with RET fusion |
|
KAKENHI Grant-in-Aid for Scientific Research (B) | Study on molecular procedures developing oncogene fusion-positive lung cancer |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
KIF5B-RET fusions in lung adenocarcinoma | ||
Development of lung adenocarcinomas with exclusive dependence on oncogene fusions | ||
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma | ||
Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis | ||
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma | ||
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic Vulnerabilities |
Controlled access users
No use of the controlled access data has been recorded.